Allworth Financial’s Y-mAbs Therapeutics YMAB Stock Holding History

Allworth Financial’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-201	Closed	-$907	–	5067
2025 Q2	$907	Buy	+201	New	+$903	﹤0.01%	3985
2022 Q4	–	Sell	-51	Closed	-$1K	–	3225
2022 Q3	$1K	Hold	51	–	–	﹤0.01%	2554
2022 Q2	$1K	Buy	+51	New	+$595	﹤0.01%	2298

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allworth Financial's YMAB Position: Q3 2025 in Review

Allworth Financial sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 201 shares — an estimated $907 sold.

Allworth Financial first reported a position in YMAB in Q2 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

Allworth Financial reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
Allworth Financial sold 201 Y-mAbs Therapeutics shares in Q3 2025, an estimated $907.
Allworth Financial first reported a position in Y-mAbs Therapeutics in Q2 2022 and held it in 3 quarters.
Allworth Financial's Y-mAbs Therapeutics position peaked at $1K in Q3 2022.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Allworth Financial's 13F filing for Q3 2025, filed 2 Dec 2025.